Nutrition and Dietetics
Brighton, Sussex, BN2 5BE, United Kingdom
NCT Number: NCT04515940
This is an acceptability study (including gastrointestinal tolerance, compliance and palatability) of a high energy peptide based paediatric oral nutritional supplement for children over 12 months of age.
The acceptability data from a minimum of 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS).
Looking for future studies?
Notify Me1 year–10 year
All sexes
Observational
Brighton, Sussex, BN2 5BE, United Kingdom
Fifteen (15) participants, aged 12 months and over, requiring a high energy peptide based oral nutritional supplement drink for the dietary management.
The ACBS requirement for evaluable data on 15 participants has informed the trial's recruitment target; however, we may need to exceed this target if any patients give their consent to join the study but then decide not to participate in the study. Participants who join the study and begin using the product would count towards the recruitment total and their data would be included in a submission to the ACBS whether they complete the 7-day study period or not.
Each potential participant must meet all of the inclusion criteria and not meet any of the exclusion criteria.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
I. Children aged 1 year and over who require 1-3 bottles of an oral nutritional peptide based supplement drink II. Children who require an oral nutritional supplement or who are already established on a nutritional supplement drink III. Children who require a nutritional supplement drink as bolus feeding via a feeding tube.
IV. Children being able to communicate views of acceptability V. Willingly given, written, informed consent from patient or parent/guardian. VI. Willingly given, written assent (if appropriate).
Exclusion criteria
I. Inability to comply with the study protocol, in the opinion of the investigator.
II. Contraindications to any feed ingredients (see nutritional table and ingredients list) III. Require a milk free diet IV. Children under the age of 12 months V. Emergencies
prospective acceptability study
Time frame: Day 7 from baseline
Daily record via participant diary:
How many feeds taken and volume prescribed each day
Questionnaires to children and or parents for the evaluation of the acceptability and ease of use of the milk supplement drink Diarrhoea, constipation, bloating, distension, nausea, vomitting, burping, abdominal pain
Time frame: Day 7 from baseline
volume suggested versus consumed
Time frame: Day 8 from baseline
At baseline
Time frame: Day 8 from baseline
At basline
Société des Produits Nestlé (SPN)
Industry
Evaluation of the Acceptability (including Gastrointestinal Tolerance, Compliance and Palatability) of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children Over 12 Months of Age
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04150120
Acquired Immunodeficiency Syndrome, Adherence, Patient
Copenhagen, Denmark
View Trial DetailsNCT06356103
Child Nutrition Disorders, Nervous System Diseases
Alexandria, Egypt
View Trial DetailsNCT06427525
Adolescents, Behavior
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05244785
Child Nutrition Disorders, Development, Adolescent
Shenzhen, Guangdong, China
View Trial Details